Eunsung Global (CEO Lee Ki-se), a medical aesthetics company, strengthened its position in the global market by participating in the 'IMCAS World Congress 2025', the International Society of Aesthetic Plastic Surgery, held in Paris, France from January 30 to February 1.
IMCAS (International Master Course on Aging Science) is the world's largest aesthetic, plastic, and dermatological conference held annually in Paris, France, where the latest aesthetic medical device technology and trends are shared.
At this conference, Eunsung Global attracted the attention of global medical professionals and industry insiders by introducing a variety of products that apply various technologies, including ▲HIFU (High Intensity Focused Ultrasound), ▲RF (Radio Frequency), ▲Needle RF (Microneedle Radio Frequency), and ▲Drug Injectors. Representative products include ▲ULTLINE ▲Duet V ▲Focus Dual ▲Vital Injector3, etc.
Eunsung Global held a symposium during this conference and revealed the clinical results of 'Ultraline'. Dr. Ariel Haus, a British KOL, gave a lecture on the topic of 'Cutting edge technology for face & body transformation using HIFU', and over 80 medical professionals and industry experts attended, confirming the high interest in the effectiveness and technology of Ultraline.
A representative of Eunsung Global said, “Through our participation in IMCAS Paris 2025, we were able to further strengthen Eunsung Global’s position in the global market,” adding, “Our diverse product lines, including Ultraline, have proven their competitiveness by receiving positive responses from global medical professionals. We will continue to solidify our position in the global market based on differentiated technology and reliable clinical data.”
- See more related articles
You must be logged in to post a comment.